The Ehlers-Danlos syndromes.

Area of Science:

• Genetics and Molecular Biology
• Rheumatology and Connective Tissue Diseases
• Medical Genetics

Background:

• Ehlers-Danlos syndromes (EDS) encompass a group of inherited connective tissue disorders.
• Common clinical features include joint hypermobility, skin hyperextensibility, poor wound healing, and easy bruising.
• Fourteen distinct EDS types are recognized, with the molecular basis identified for 13.

Purpose of the Study:

• To provide an overview of the current understanding of Ehlers-Danlos syndromes.
• To highlight the genetic underpinnings of various EDS types.
• To emphasize the systemic impact and management challenges of EDS.

Main Methods:

• Review of genetic and clinical literature pertaining to Ehlers-Danlos syndromes.
• Analysis of known genetic variants associated with 13 EDS types.
• Summary of current diagnostic and management strategies.

Main Results:

• Genetic variants in 20 genes, primarily encoding fibrillar collagens (types I, III, V) and related enzymes, explain 13 EDS types.
• The molecular basis for the hypermobile type of EDS remains elusive.
• EDS manifestations affect nearly every organ system, complicating diagnosis and management.

Conclusions:

• EDS are complex genetic disorders with widespread systemic effects.
• Current management focuses on multidisciplinary care and complication surveillance, as specific therapies are unavailable.
• Further research is needed to elucidate the genetic causes of hypermobile EDS and develop targeted treatments.